{"id":"W2615945276","doi":"10.6004/jnccn.2017.0075","title":"Immunotherapies for Lung Cancer","year":2017,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Pembrolizumab; Atezolizumab; Medicine; Nivolumab; Immunotherapy; Oncology; Lung cancer; PD-L1; Internal medicine; Standard of care; First line; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004981889,0.0002676841,0.0003244489,0.0005539374,0.0002475124,0.0006898341,0.0002551465,0.0004607959,0.005798281],"category_scores_gemma":[0.0004920241,0.00007510218,0.0004411697,0.000282076,0.0002333195,0.0005126066,0.0005231049,0.001659081,0.002683376],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006064568,"about_ca_system_score_gemma":0.0004579699,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003309743,"about_ca_topic_score_gemma":0.001077466,"domain_scores_codex":[0.9998199,0.00004466024,0.00001167748,0.00002147681,0.00007110551,0.00003110772],"domain_scores_gemma":[0.9998583,0.00002553474,0.00002375963,0.0000136772,0.00004582453,0.00003306691],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000322106,0.0003553128,0.001016139,0.001367938,0.0001142594,0.0004045583,0.00007811471,0.000404476,0.02004343,0.0140311,0.08206265,0.8797999],"study_design_scores_gemma":[0.0001789915,0.0005267566,0.002140886,0.0005257842,0.00006683489,0.001361544,0.00003791201,0.0003289302,0.005319566,0.006459187,0.9830403,0.00001334293],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01844195,0.8894203,0.006070252,0.02389604,0.007850977,0.0002236614,0.0004903782,0.0002864694,0.05332001],"genre_scores_gemma":[0.2229047,0.6768333,0.009885984,0.01778118,0.006410017,0.00038365,0.001588787,0.00008302237,0.06412941],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005798281,"threshold_uncertainty_score":0.0193972,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05760166304265469,"score_gpt":0.3876294147813151,"score_spread":0.3300277517386604,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}